A detailed history of Bahl & Gaynor Inc transactions in Medtronic PLC stock. As of the latest transaction made, Bahl & Gaynor Inc holds 73,108 shares of MDT stock, worth $5.66 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
73,108
Previous 134,116 45.49%
Holding current value
$5.66 Million
Previous $11 Million 42.33%
% of portfolio
0.04%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$82.84 - $88.09 $5.05 Million - $5.37 Million
-61,008 Reduced 45.49%
73,108 $6.37 Million
Q4 2023

Feb 02, 2024

SELL
$69.43 - $83.43 $44.9 Million - $53.9 Million
-646,082 Reduced 82.81%
134,116 $11 Million
Q3 2023

Nov 03, 2023

SELL
$78.22 - $90.4 $24.8 Million - $28.7 Million
-317,344 Reduced 28.91%
780,198 $61.1 Million
Q2 2023

Aug 14, 2023

SELL
$79.47 - $91.38 $30.5 Million - $35.1 Million
-383,807 Reduced 25.91%
1,097,542 $96.7 Million
Q1 2023

May 03, 2023

SELL
$76.72 - $87.58 $47 Million - $53.7 Million
-612,887 Reduced 29.27%
1,481,349 $119 Million
Q4 2022

Feb 10, 2023

SELL
$76.18 - $87.74 $31.9 Million - $36.7 Million
-418,716 Reduced 16.66%
2,094,236 $163 Million
Q3 2022

Nov 14, 2022

BUY
$80.75 - $95.31 $2.03 Million - $2.4 Million
25,161 Added 1.01%
2,512,952 $203 Million
Q2 2022

Aug 08, 2022

BUY
$87.4 - $113.09 $68.9 Million - $89.2 Million
788,483 Added 46.4%
2,487,791 $223 Million
Q1 2022

May 12, 2022

SELL
$100.58 - $112.38 $74.9 Million - $83.6 Million
-744,248 Reduced 30.46%
1,699,308 $189 Million
Q4 2021

Feb 10, 2022

BUY
$99.53 - $127.75 $24.4 Million - $31.3 Million
245,187 Added 11.15%
2,443,556 $253 Million
Q3 2021

Nov 15, 2021

BUY
$122.75 - $135.17 $23.6 Million - $26 Million
192,304 Added 9.59%
2,198,369 $276 Million
Q2 2021

Aug 06, 2021

SELL
$118.19 - $131.5 $3.33 Million - $3.7 Million
-28,172 Reduced 1.38%
2,006,065 $249 Million
Q1 2021

May 11, 2021

SELL
$111.18 - $119.74 $6.33 Million - $6.82 Million
-56,958 Reduced 2.72%
2,034,237 $240 Million
Q4 2020

Feb 02, 2021

SELL
$100.57 - $117.14 $5.67 Million - $6.61 Million
-56,417 Reduced 2.63%
2,091,195 $245 Million
Q3 2020

Nov 12, 2020

SELL
$90.13 - $108.78 $331,137 - $399,657
-3,674 Reduced 0.17%
2,147,612 $223 Million
Q2 2020

Aug 13, 2020

BUY
$84.11 - $103.33 $1.78 Million - $2.19 Million
21,188 Added 0.99%
2,151,286 $197 Million
Q1 2020

May 26, 2020

BUY
$72.92 - $121.3 $104 Million - $172 Million
1,421,188 Added 200.48%
2,130,098 $192 Million
Q1 2020

May 15, 2020

SELL
$72.92 - $121.3 $106 Million - $177 Million
-1,456,525 Reduced 67.26%
708,910 $63.9 Million
Q4 2019

Feb 14, 2020

BUY
$104.49 - $114.54 $2.23 Million - $2.44 Million
21,326 Added 0.99%
2,165,435 $246 Million
Q3 2019

Nov 14, 2019

BUY
$98.02 - $111.18 $11.8 Million - $13.4 Million
120,595 Added 5.96%
2,144,109 $233 Million
Q2 2019

Aug 12, 2019

BUY
$84.15 - $99.38 $4.02 Million - $4.74 Million
47,716 Added 2.42%
2,023,514 $197 Million
Q1 2019

May 13, 2019

BUY
$82.45 - $93.79 $3.16 Million - $3.59 Million
38,305 Added 1.98%
1,975,798 $180 Million
Q4 2018

Feb 12, 2019

BUY
$85.8 - $99.49 $54.9 Million - $63.7 Million
639,768 Added 49.3%
1,937,493 $176 Million
Q3 2018

Nov 09, 2018

SELL
$85.91 - $99.17 $55.1 Million - $63.6 Million
-641,545 Reduced 33.08%
1,297,725 $128 Million
Q2 2018

Aug 14, 2018

SELL
$77.48 - $87.83 $144 Million - $163 Million
-1,856,934 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$76.55 - $87.26 $6.82 Million - $7.77 Million
-89,096 Reduced 4.58%
1,856,934 $149 Million
Q4 2017

Feb 13, 2018

BUY
$76.93 - $83.5 $11.9 Million - $12.9 Million
154,380 Added 8.62%
1,946,030 $157 Million
Q3 2017

Nov 13, 2017

BUY
$77.71 - $84.6 $1.26 Million - $1.37 Million
16,239 Added 0.91%
1,791,650 $139 Million
Q2 2017

Aug 11, 2017

BUY
N/A
428,432 Added 31.81%
1,775,411 $158 Million
Q2 2017

Aug 10, 2017

BUY
N/A
1,346,979
1,346,979 $95.9 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $103B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.